Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis.
about
Disparities in the Magnitude of Human Immunodeficiency Virus-related Opportunistic Infections Between High and Low/Middle-income Countries: Is Highly Active Antiretroviral Therapy Changing the Trend?Antiretroviral treatment cohort analysis using time-updated CD4 counts: assessment of bias with different analytic methodsThe cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysisPatient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability.Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaborationEarly severe morbidity and resource utilization in South African adults on antiretroviral therapy.Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort.High prevalence of HIV-1 drug resistance among patients on first-line antiretroviral treatment in Lomé, Togo.Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectivenessSevere morbidity after antiretroviral (ART) initiation: active surveillance in HIV care programs, the IeDEA West Africa collaborationLipid Profile of Anti-Retroviral Treatment-Naïve HIV-Infected Patients in Jos, NigeriaCould early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era.[Clinical, biological, therapeutic and evolving profile of patients with HIV infection hospitalized at Infectious and tropical diseases unit in Abidjan (Ivory Coast)].Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India.
P2860
Q26752860-B24304EA-17A1-4C8C-9578-5A9BB3DA98A6Q28478065-08283B13-BCD8-4B5F-B12D-740F88A5B3CEQ28483035-9BBCFFEF-1EF3-4726-B466-ECD7022C5422Q30528513-A9A23533-1F52-425D-BB00-C3DF73C55CE2Q30583563-D5CCE4D3-7A88-4757-99F2-38766FEF7D09Q33518021-0ED6B225-4CAC-4362-8094-A8EE3422FC82Q33611305-F10C53E8-F6E5-4332-9601-61F3399168D6Q35074204-FA5AE837-C121-4B9A-93FC-AB971D313E55Q35076875-471D0761-7054-45C3-8C18-C53448722178Q35217495-61396261-B3F4-42DC-B673-9BD677836295Q35409929-38966BCC-088C-4EDC-8539-151D35AB4FEBQ36789642-83B18103-AE3D-42BE-B7E0-7297A8BFF104Q37483442-ABA3B0AE-5F5E-46BF-8D1A-77E5810B9B2EQ37693285-2CFC94E7-AD34-4796-9672-E703694FAA4FQ44778322-5471F142-C6F1-4272-B687-D1B2FDC63EFAQ52604813-EA722135-024B-42F8-AE60-804D9B8B5DBE
P2860
Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Morbidity before and after HAA ...... s: a recurrent event analysis.
@en
Morbidity before and after HAA ...... s: a recurrent event analysis.
@nl
type
label
Morbidity before and after HAA ...... s: a recurrent event analysis.
@en
Morbidity before and after HAA ...... s: a recurrent event analysis.
@nl
prefLabel
Morbidity before and after HAA ...... s: a recurrent event analysis.
@en
Morbidity before and after HAA ...... s: a recurrent event analysis.
@nl
P2093
P356
P1476
Morbidity before and after HAA ...... s: a recurrent event analysis.
@en
P2093
Ahmadou Alioum
André Inwoley
Catherine Seyler
Eugène Messou
P304
P356
10.1089/AID.2006.0308
P577
2007-11-01T00:00:00Z